SlideShare una empresa de Scribd logo
1 de 12
CASO CLÍNICO
PERFIL HEMATOLOGICO
01/01/2023 11/01/2023 23/01/2023
LEU 6.74 6.27 7.76
LINF 36% 43.2% 36.2
HB 12.4 11 11.3
PLAQ X000 714 479 383
hematocrito 41.3 35.4 35.9
VCM 78.5 77.8 77.4
MONOCITOS 4 5.3 4.3
NEUTROFILOS
SEGMENTADOS
57 48.8 57.2
PERFIL HEPÁTICO
24/12/2022 01/01/2023 11/01/2023 22/01/2023 23/01/2023
TGO 38 44 20.2
TGP 46 37 16.3
FA 3.35 125 104
LDH 526 138 21.2
ALB 3.7
GLUCOSA 95 94 89
BD 0.316 0.101 0.11
BI 0.211 0.149 0.211
Prot T 0.007 8.46 7.83
PERFIL DE COAGULACIÓN
24/12/2022 01/01/2023 11/01/2023 23/01/2023
PTT 32.91 32.24
TP 12.21 11.68 12.09 11.96
INR 1.118
DIMERO D 4042
AZOADOS
24/12/2022 01/01/2023 11/01/2023 22/01/2023 23/01/2023
U 30 36 31.8 29.7
Cr 0.44 0.51 0.65 0.58
MG 2.08 2.07 2.07 1.91
GGT 68 20
Ca 8.91 9.3
K 3.25 4.4 4.38 4.2
Na 139 138 138 135
Cl 106.6 98.5 104.9
PERFIL REUMATOLOGICO
PERFIL REUMOATOLOGICO 20/01/2023 12/01/2023 13/01/2023 19/01/2023 22/01/23
ANA PATRON MOTEADO
1/3200
PATRONCITOPLAMATI
CO 1/3200
ANTI DNAds 16.65
ENA
Anti PM-Scl: POSITIVO ++
Anti SS-A: POSITIVO +
Anti Sm: INDETERMINADO
Anti RNP/Sm: POSITIVO +
Anti Ribosomal P:
INDETERMINADO
Anti PCNA:
INDETERMINADO
ANTICARDIOLIPINAS IGG 5.64
ANTITRIOGLOBULINA 11.72
ANCA ANCA P <2
ANCA C <2
ANTI CCP 6.47
ANTI,ICROSOMAL 5.65
C3 75 70
C4 21 3 4
REACTANTES DE FASE AGUDA:
24/12/2022 01/01/2023 11/01/2023 23/01/2023
PCR 32.71 1.66 0.5 0.85
INMUNOGLOBULIN
A M
167
INMUNO
GLOBULINA A
543
INMUNOGLOBULIN
A G
2318
EXAMEN DE ORINA /PROTEINURIA
EXAMEN DE ORINA 23/01/2023
LEU 2-0XC
HEMAT NO SE OBS
PROT -
CILINDRO -
ESTEREASA LEU -
NITRITOS -
BACTERIAS ESCASAS
PROTEINAS 24 H
DEPURACION DE Cr
MICROBIOLOGIA:
29/12/2022
BK ESPUTO NEGAT
BK HECES
BK ORINA
19.01.23: Autoanticuerpo Anti PM-Scl: POSITIVO
++,Autoanticuerpo Anti SS-A: POSITIVO +,Autoanticuerpo Anti
RNP/Sm: POSITIVO +
08/01/23
TEM DE TORAX; SIN MATERIAL DE
CONTRASTE
focos en vidrio deslustrado en lóbulos superiores de aspecto
inflamatorio.
bandas atelectasicas a nivel de los segmentos posteriores de
ambos campos pulmonares.
derrame pleural derecho
24/12/22
TEM sc torax:
compromiso pleuroparenquimal bilateral,
adenopatia paratraqueal inferior de
10mmoteinuria 0.09 g/24h , dep crea 120
16/01/23
RMN de encéfalo
Focos de gliosis inespecífica a predominio de
lóbulos frontales, según descripción.
24/12/22
PRTEM CC de
cerebro:
estudio normal.
IMAGENES
23/01/23
TEM DE TORAX S/C
compromiso intersticial de predominio subpleural y posterobasal y distensión
esofágica distal, dc espectro de esclerosis sistémica.
29/8/22
IMAGENES

Más contenido relacionado

Último

Induccion Personal Mision S&A (nueva).pdf
Induccion Personal Mision S&A (nueva).pdfInduccion Personal Mision S&A (nueva).pdf
Induccion Personal Mision S&A (nueva).pdf
stefatoro1392
 
7.2 -La guerra civil. Evolución de los bandos y consecuencias-Marta y Elena (...
7.2 -La guerra civil. Evolución de los bandos y consecuencias-Marta y Elena (...7.2 -La guerra civil. Evolución de los bandos y consecuencias-Marta y Elena (...
7.2 -La guerra civil. Evolución de los bandos y consecuencias-Marta y Elena (...
jose880240
 

Último (9)

Blue_Aesthetic_Mood_Board_Brand_Inspiration_Poster.pdf
Blue_Aesthetic_Mood_Board_Brand_Inspiration_Poster.pdfBlue_Aesthetic_Mood_Board_Brand_Inspiration_Poster.pdf
Blue_Aesthetic_Mood_Board_Brand_Inspiration_Poster.pdf
 
Induccion Personal Mision S&A (nueva).pdf
Induccion Personal Mision S&A (nueva).pdfInduccion Personal Mision S&A (nueva).pdf
Induccion Personal Mision S&A (nueva).pdf
 
13.05)PRIMER GRUPO CARNES 2024 - RELACION DE FOTOS CORRECTAS.pdf
13.05)PRIMER GRUPO CARNES 2024 - RELACION DE FOTOS CORRECTAS.pdf13.05)PRIMER GRUPO CARNES 2024 - RELACION DE FOTOS CORRECTAS.pdf
13.05)PRIMER GRUPO CARNES 2024 - RELACION DE FOTOS CORRECTAS.pdf
 
7.2 -La guerra civil. Evolución de los bandos y consecuencias-Marta y Elena (...
7.2 -La guerra civil. Evolución de los bandos y consecuencias-Marta y Elena (...7.2 -La guerra civil. Evolución de los bandos y consecuencias-Marta y Elena (...
7.2 -La guerra civil. Evolución de los bandos y consecuencias-Marta y Elena (...
 
TECNOLOGIA ARQUITECTONICA - CASO IQUITOS - PERU
TECNOLOGIA ARQUITECTONICA - CASO IQUITOS - PERUTECNOLOGIA ARQUITECTONICA - CASO IQUITOS - PERU
TECNOLOGIA ARQUITECTONICA - CASO IQUITOS - PERU
 
Dominio de internet, materia de diseño web
Dominio de internet, materia de diseño webDominio de internet, materia de diseño web
Dominio de internet, materia de diseño web
 
BOTONES para diseño grafico de paginas web
BOTONES para diseño grafico  de paginas webBOTONES para diseño grafico  de paginas web
BOTONES para diseño grafico de paginas web
 
Planos seriados, conceptos, caracterización y aplicaciones
Planos seriados, conceptos, caracterización y aplicacionesPlanos seriados, conceptos, caracterización y aplicaciones
Planos seriados, conceptos, caracterización y aplicaciones
 
word-ejercicios-tabulaciones-taller..doc
word-ejercicios-tabulaciones-taller..docword-ejercicios-tabulaciones-taller..doc
word-ejercicios-tabulaciones-taller..doc
 

Destacado

How Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental HealthHow Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental Health
ThinkNow
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
Kurio // The Social Media Age(ncy)
 

Destacado (20)

2024 State of Marketing Report – by Hubspot
2024 State of Marketing Report – by Hubspot2024 State of Marketing Report – by Hubspot
2024 State of Marketing Report – by Hubspot
 
Everything You Need To Know About ChatGPT
Everything You Need To Know About ChatGPTEverything You Need To Know About ChatGPT
Everything You Need To Know About ChatGPT
 
Product Design Trends in 2024 | Teenage Engineerings
Product Design Trends in 2024 | Teenage EngineeringsProduct Design Trends in 2024 | Teenage Engineerings
Product Design Trends in 2024 | Teenage Engineerings
 
How Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental HealthHow Race, Age and Gender Shape Attitudes Towards Mental Health
How Race, Age and Gender Shape Attitudes Towards Mental Health
 
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdfAI Trends in Creative Operations 2024 by Artwork Flow.pdf
AI Trends in Creative Operations 2024 by Artwork Flow.pdf
 
Skeleton Culture Code
Skeleton Culture CodeSkeleton Culture Code
Skeleton Culture Code
 
PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024PEPSICO Presentation to CAGNY Conference Feb 2024
PEPSICO Presentation to CAGNY Conference Feb 2024
 
Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)Content Methodology: A Best Practices Report (Webinar)
Content Methodology: A Best Practices Report (Webinar)
 
How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024How to Prepare For a Successful Job Search for 2024
How to Prepare For a Successful Job Search for 2024
 
Social Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie InsightsSocial Media Marketing Trends 2024 // The Global Indie Insights
Social Media Marketing Trends 2024 // The Global Indie Insights
 
Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024Trends In Paid Search: Navigating The Digital Landscape In 2024
Trends In Paid Search: Navigating The Digital Landscape In 2024
 
5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary5 Public speaking tips from TED - Visualized summary
5 Public speaking tips from TED - Visualized summary
 
ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd ChatGPT and the Future of Work - Clark Boyd
ChatGPT and the Future of Work - Clark Boyd
 
Getting into the tech field. what next
Getting into the tech field. what next Getting into the tech field. what next
Getting into the tech field. what next
 
Google's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search IntentGoogle's Just Not That Into You: Understanding Core Updates & Search Intent
Google's Just Not That Into You: Understanding Core Updates & Search Intent
 
How to have difficult conversations
How to have difficult conversations How to have difficult conversations
How to have difficult conversations
 
Introduction to Data Science
Introduction to Data ScienceIntroduction to Data Science
Introduction to Data Science
 
Time Management & Productivity - Best Practices
Time Management & Productivity -  Best PracticesTime Management & Productivity -  Best Practices
Time Management & Productivity - Best Practices
 
The six step guide to practical project management
The six step guide to practical project managementThe six step guide to practical project management
The six step guide to practical project management
 
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
Beginners Guide to TikTok for Search - Rachel Pearson - We are Tilt __ Bright...
 

.caso.pptx

  • 2. PERFIL HEMATOLOGICO 01/01/2023 11/01/2023 23/01/2023 LEU 6.74 6.27 7.76 LINF 36% 43.2% 36.2 HB 12.4 11 11.3 PLAQ X000 714 479 383 hematocrito 41.3 35.4 35.9 VCM 78.5 77.8 77.4 MONOCITOS 4 5.3 4.3 NEUTROFILOS SEGMENTADOS 57 48.8 57.2
  • 3. PERFIL HEPÁTICO 24/12/2022 01/01/2023 11/01/2023 22/01/2023 23/01/2023 TGO 38 44 20.2 TGP 46 37 16.3 FA 3.35 125 104 LDH 526 138 21.2 ALB 3.7 GLUCOSA 95 94 89 BD 0.316 0.101 0.11 BI 0.211 0.149 0.211 Prot T 0.007 8.46 7.83
  • 4. PERFIL DE COAGULACIÓN 24/12/2022 01/01/2023 11/01/2023 23/01/2023 PTT 32.91 32.24 TP 12.21 11.68 12.09 11.96 INR 1.118 DIMERO D 4042
  • 5. AZOADOS 24/12/2022 01/01/2023 11/01/2023 22/01/2023 23/01/2023 U 30 36 31.8 29.7 Cr 0.44 0.51 0.65 0.58 MG 2.08 2.07 2.07 1.91 GGT 68 20 Ca 8.91 9.3 K 3.25 4.4 4.38 4.2 Na 139 138 138 135 Cl 106.6 98.5 104.9
  • 6. PERFIL REUMATOLOGICO PERFIL REUMOATOLOGICO 20/01/2023 12/01/2023 13/01/2023 19/01/2023 22/01/23 ANA PATRON MOTEADO 1/3200 PATRONCITOPLAMATI CO 1/3200 ANTI DNAds 16.65 ENA Anti PM-Scl: POSITIVO ++ Anti SS-A: POSITIVO + Anti Sm: INDETERMINADO Anti RNP/Sm: POSITIVO + Anti Ribosomal P: INDETERMINADO Anti PCNA: INDETERMINADO ANTICARDIOLIPINAS IGG 5.64 ANTITRIOGLOBULINA 11.72 ANCA ANCA P <2 ANCA C <2 ANTI CCP 6.47 ANTI,ICROSOMAL 5.65 C3 75 70 C4 21 3 4
  • 7. REACTANTES DE FASE AGUDA: 24/12/2022 01/01/2023 11/01/2023 23/01/2023 PCR 32.71 1.66 0.5 0.85 INMUNOGLOBULIN A M 167 INMUNO GLOBULINA A 543 INMUNOGLOBULIN A G 2318
  • 8. EXAMEN DE ORINA /PROTEINURIA EXAMEN DE ORINA 23/01/2023 LEU 2-0XC HEMAT NO SE OBS PROT - CILINDRO - ESTEREASA LEU - NITRITOS - BACTERIAS ESCASAS PROTEINAS 24 H DEPURACION DE Cr
  • 9. MICROBIOLOGIA: 29/12/2022 BK ESPUTO NEGAT BK HECES BK ORINA 19.01.23: Autoanticuerpo Anti PM-Scl: POSITIVO ++,Autoanticuerpo Anti SS-A: POSITIVO +,Autoanticuerpo Anti RNP/Sm: POSITIVO +
  • 10. 08/01/23 TEM DE TORAX; SIN MATERIAL DE CONTRASTE focos en vidrio deslustrado en lóbulos superiores de aspecto inflamatorio. bandas atelectasicas a nivel de los segmentos posteriores de ambos campos pulmonares. derrame pleural derecho 24/12/22 TEM sc torax: compromiso pleuroparenquimal bilateral, adenopatia paratraqueal inferior de 10mmoteinuria 0.09 g/24h , dep crea 120 16/01/23 RMN de encéfalo Focos de gliosis inespecífica a predominio de lóbulos frontales, según descripción. 24/12/22 PRTEM CC de cerebro: estudio normal. IMAGENES 23/01/23 TEM DE TORAX S/C compromiso intersticial de predominio subpleural y posterobasal y distensión esofágica distal, dc espectro de esclerosis sistémica.
  • 11.